The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Microbial CDMO Service Market Research Report 2025
Synopsis
The global Microbial CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Microbial CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbial CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbial CDMO Service in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbial CDMO Service include Lonza, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Laurus Bio, BOC Sciences, AbbVie, Cytovance Biologics, ADL Biopharma, EUROAPI, KBI Biopharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbial CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial CDMO Service.
The Microbial CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbial CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Laurus Bio
BOC Sciences
AbbVie
Cytovance Biologics
ADL Biopharma
EUROAPI
KBI Biopharma
Segment by Type
Fermentation Scale-Up
cGMP Manufacturing
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbial CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Microbial CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Microbial CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Microbial CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Microbial CDMO Service in SMBs is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Microbial CDMO Service include Lonza, AGC Biologics, FUJIFILM Diosynth Biotechnologies, Laurus Bio, BOC Sciences, AbbVie, Cytovance Biologics, ADL Biopharma, EUROAPI, KBI Biopharma, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Microbial CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Microbial CDMO Service.
The Microbial CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Microbial CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Microbial CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Lonza
AGC Biologics
FUJIFILM Diosynth Biotechnologies
Laurus Bio
BOC Sciences
AbbVie
Cytovance Biologics
ADL Biopharma
EUROAPI
KBI Biopharma
Segment by Type
Fermentation Scale-Up
cGMP Manufacturing
Other
Segment by Application
SMBs
Large Companies
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Microbial CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Microbial CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Fermentation Scale-Up
1.2.3 cGMP Manufacturing
1.2.4 Other
1.3 Market by Application
1.3.1 Global Microbial CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 SMBs
1.3.3 Large Companies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Microbial CDMO Service Market Perspective (2019-2030)
2.2 Global Microbial CDMO Service Growth Trends by Region
2.2.1 Global Microbial CDMO Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Microbial CDMO Service Historic Market Size by Region (2019-2024)
2.2.3 Microbial CDMO Service Forecasted Market Size by Region (2025-2030)
2.3 Microbial CDMO Service Market Dynamics
2.3.1 Microbial CDMO Service Industry Trends
2.3.2 Microbial CDMO Service Market Drivers
2.3.3 Microbial CDMO Service Market Challenges
2.3.4 Microbial CDMO Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Microbial CDMO Service Players by Revenue
3.1.1 Global Top Microbial CDMO Service Players by Revenue (2019-2024)
3.1.2 Global Microbial CDMO Service Revenue Market Share by Players (2019-2024)
3.2 Global Microbial CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Microbial CDMO Service Revenue
3.4 Global Microbial CDMO Service Market Concentration Ratio
3.4.1 Global Microbial CDMO Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Microbial CDMO Service Revenue in 2023
3.5 Global Key Players of Microbial CDMO Service Head office and Area Served
3.6 Global Key Players of Microbial CDMO Service, Product and Application
3.7 Global Key Players of Microbial CDMO Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Microbial CDMO Service Breakdown Data by Type
4.1 Global Microbial CDMO Service Historic Market Size by Type (2019-2024)
4.2 Global Microbial CDMO Service Forecasted Market Size by Type (2025-2030)
5 Microbial CDMO Service Breakdown Data by Application
5.1 Global Microbial CDMO Service Historic Market Size by Application (2019-2024)
5.2 Global Microbial CDMO Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Microbial CDMO Service Market Size (2019-2030)
6.2 North America Microbial CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Microbial CDMO Service Market Size by Country (2019-2024)
6.4 North America Microbial CDMO Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Microbial CDMO Service Market Size (2019-2030)
7.2 Europe Microbial CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Microbial CDMO Service Market Size by Country (2019-2024)
7.4 Europe Microbial CDMO Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Microbial CDMO Service Market Size (2019-2030)
8.2 Asia-Pacific Microbial CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Microbial CDMO Service Market Size by Region (2019-2024)
8.4 Asia-Pacific Microbial CDMO Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Microbial CDMO Service Market Size (2019-2030)
9.2 Latin America Microbial CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Microbial CDMO Service Market Size by Country (2019-2024)
9.4 Latin America Microbial CDMO Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Microbial CDMO Service Market Size (2019-2030)
10.2 Middle East & Africa Microbial CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Microbial CDMO Service Market Size by Country (2019-2024)
10.4 Middle East & Africa Microbial CDMO Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza Microbial CDMO Service Introduction
11.1.4 Lonza Revenue in Microbial CDMO Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 AGC Biologics
11.2.1 AGC Biologics Company Details
11.2.2 AGC Biologics Business Overview
11.2.3 AGC Biologics Microbial CDMO Service Introduction
11.2.4 AGC Biologics Revenue in Microbial CDMO Service Business (2019-2024)
11.2.5 AGC Biologics Recent Development
11.3 FUJIFILM Diosynth Biotechnologies
11.3.1 FUJIFILM Diosynth Biotechnologies Company Details
11.3.2 FUJIFILM Diosynth Biotechnologies Business Overview
11.3.3 FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Introduction
11.3.4 FUJIFILM Diosynth Biotechnologies Revenue in Microbial CDMO Service Business (2019-2024)
11.3.5 FUJIFILM Diosynth Biotechnologies Recent Development
11.4 Laurus Bio
11.4.1 Laurus Bio Company Details
11.4.2 Laurus Bio Business Overview
11.4.3 Laurus Bio Microbial CDMO Service Introduction
11.4.4 Laurus Bio Revenue in Microbial CDMO Service Business (2019-2024)
11.4.5 Laurus Bio Recent Development
11.5 BOC Sciences
11.5.1 BOC Sciences Company Details
11.5.2 BOC Sciences Business Overview
11.5.3 BOC Sciences Microbial CDMO Service Introduction
11.5.4 BOC Sciences Revenue in Microbial CDMO Service Business (2019-2024)
11.5.5 BOC Sciences Recent Development
11.6 AbbVie
11.6.1 AbbVie Company Details
11.6.2 AbbVie Business Overview
11.6.3 AbbVie Microbial CDMO Service Introduction
11.6.4 AbbVie Revenue in Microbial CDMO Service Business (2019-2024)
11.6.5 AbbVie Recent Development
11.7 Cytovance Biologics
11.7.1 Cytovance Biologics Company Details
11.7.2 Cytovance Biologics Business Overview
11.7.3 Cytovance Biologics Microbial CDMO Service Introduction
11.7.4 Cytovance Biologics Revenue in Microbial CDMO Service Business (2019-2024)
11.7.5 Cytovance Biologics Recent Development
11.8 ADL Biopharma
11.8.1 ADL Biopharma Company Details
11.8.2 ADL Biopharma Business Overview
11.8.3 ADL Biopharma Microbial CDMO Service Introduction
11.8.4 ADL Biopharma Revenue in Microbial CDMO Service Business (2019-2024)
11.8.5 ADL Biopharma Recent Development
11.9 EUROAPI
11.9.1 EUROAPI Company Details
11.9.2 EUROAPI Business Overview
11.9.3 EUROAPI Microbial CDMO Service Introduction
11.9.4 EUROAPI Revenue in Microbial CDMO Service Business (2019-2024)
11.9.5 EUROAPI Recent Development
11.10 KBI Biopharma
11.10.1 KBI Biopharma Company Details
11.10.2 KBI Biopharma Business Overview
11.10.3 KBI Biopharma Microbial CDMO Service Introduction
11.10.4 KBI Biopharma Revenue in Microbial CDMO Service Business (2019-2024)
11.10.5 KBI Biopharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of TablesList of Tables
Table 1. Global Microbial CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Fermentation Scale-Up
Table 3. Key Players of cGMP Manufacturing
Table 4. Key Players of Other
Table 5. Global Microbial CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Microbial CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Microbial CDMO Service Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Microbial CDMO Service Market Share by Region (2019-2024)
Table 9. Global Microbial CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Microbial CDMO Service Market Share by Region (2025-2030)
Table 11. Microbial CDMO Service Market Trends
Table 12. Microbial CDMO Service Market Drivers
Table 13. Microbial CDMO Service Market Challenges
Table 14. Microbial CDMO Service Market Restraints
Table 15. Global Microbial CDMO Service Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Microbial CDMO Service Market Share by Players (2019-2024)
Table 17. Global Top Microbial CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial CDMO Service as of 2023)
Table 18. Ranking of Global Top Microbial CDMO Service Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Microbial CDMO Service Revenue (CR5 and HHI) & (2019-2024)
Table 20. Global Key Players of Microbial CDMO Service, Headquarters and Area Served
Table 21. Global Key Players of Microbial CDMO Service, Product and Application
Table 22. Global Key Players of Microbial CDMO Service, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Microbial CDMO Service Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Microbial CDMO Service Revenue Market Share by Type (2019-2024)
Table 26. Global Microbial CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Microbial CDMO Service Revenue Market Share by Type (2025-2030)
Table 28. Global Microbial CDMO Service Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Microbial CDMO Service Revenue Market Share by Application (2019-2024)
Table 30. Global Microbial CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Microbial CDMO Service Revenue Market Share by Application (2025-2030)
Table 32. North America Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Microbial CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Microbial CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Microbial CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Microbial CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Microbial CDMO Service Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Microbial CDMO Service Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Microbial CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Microbial CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Microbial CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Microbial CDMO Service Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Microbial CDMO Service Market Size by Country (2025-2030) & (US$ Million)
Table 47. Lonza Company Details
Table 48. Lonza Business Overview
Table 49. Lonza Microbial CDMO Service Product
Table 50. Lonza Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 51. Lonza Recent Development
Table 52. AGC Biologics Company Details
Table 53. AGC Biologics Business Overview
Table 54. AGC Biologics Microbial CDMO Service Product
Table 55. AGC Biologics Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 56. AGC Biologics Recent Development
Table 57. FUJIFILM Diosynth Biotechnologies Company Details
Table 58. FUJIFILM Diosynth Biotechnologies Business Overview
Table 59. FUJIFILM Diosynth Biotechnologies Microbial CDMO Service Product
Table 60. FUJIFILM Diosynth Biotechnologies Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 61. FUJIFILM Diosynth Biotechnologies Recent Development
Table 62. Laurus Bio Company Details
Table 63. Laurus Bio Business Overview
Table 64. Laurus Bio Microbial CDMO Service Product
Table 65. Laurus Bio Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 66. Laurus Bio Recent Development
Table 67. BOC Sciences Company Details
Table 68. BOC Sciences Business Overview
Table 69. BOC Sciences Microbial CDMO Service Product
Table 70. BOC Sciences Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 71. BOC Sciences Recent Development
Table 72. AbbVie Company Details
Table 73. AbbVie Business Overview
Table 74. AbbVie Microbial CDMO Service Product
Table 75. AbbVie Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 76. AbbVie Recent Development
Table 77. Cytovance Biologics Company Details
Table 78. Cytovance Biologics Business Overview
Table 79. Cytovance Biologics Microbial CDMO Service Product
Table 80. Cytovance Biologics Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 81. Cytovance Biologics Recent Development
Table 82. ADL Biopharma Company Details
Table 83. ADL Biopharma Business Overview
Table 84. ADL Biopharma Microbial CDMO Service Product
Table 85. ADL Biopharma Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 86. ADL Biopharma Recent Development
Table 87. EUROAPI Company Details
Table 88. EUROAPI Business Overview
Table 89. EUROAPI Microbial CDMO Service Product
Table 90. EUROAPI Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 91. EUROAPI Recent Development
Table 92. KBI Biopharma Company Details
Table 93. KBI Biopharma Business Overview
Table 94. KBI Biopharma Microbial CDMO Service Product
Table 95. KBI Biopharma Revenue in Microbial CDMO Service Business (2019-2024) & (US$ Million)
Table 96. KBI Biopharma Recent Development
Table 97. Research Programs/Design for This Report
Table 98. Key Data Information from Secondary Sources
Table 99. Key Data Information from Primary Sources
Table 100. Authors List of This Report
List of Figures
Figure 1. Microbial CDMO Service Picture
Figure 2. Global Microbial CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Microbial CDMO Service Market Share by Type: 2023 VS 2030
Figure 4. Fermentation Scale-Up Features
Figure 5. cGMP Manufacturing Features
Figure 6. Other Features
Figure 7. Global Microbial CDMO Service Market Size by Application (2024-2030) & (US$ Million)
Figure 8. Global Microbial CDMO Service Market Share by Application: 2023 VS 2030
Figure 9. SMBs Case Studies
Figure 10. Large Companies Case Studies
Figure 11. Microbial CDMO Service Report Years Considered
Figure 12. Global Microbial CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 13. Global Microbial CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 14. Global Microbial CDMO Service Market Share by Region: 2023 VS 2030
Figure 15. Global Microbial CDMO Service Market Share by Players in 2023
Figure 16. Global Top Microbial CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Microbial CDMO Service as of 2023)
Figure 17. The Top 10 and 5 Players Market Share by Microbial CDMO Service Revenue in 2023
Figure 18. North America Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. North America Microbial CDMO Service Market Share by Country (2019-2030)
Figure 20. United States Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Canada Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. Europe Microbial CDMO Service Market Share by Country (2019-2030)
Figure 24. Germany Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. France Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. U.K. Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Italy Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Russia Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Nordic Countries Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Asia-Pacific Microbial CDMO Service Market Share by Region (2019-2030)
Figure 32. China Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Japan Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. South Korea Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Southeast Asia Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. India Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Australia Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Latin America Microbial CDMO Service Market Share by Country (2019-2030)
Figure 40. Mexico Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Brazil Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Middle East & Africa Microbial CDMO Service Market Share by Country (2019-2030)
Figure 44. Turkey Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Saudi Arabia Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 46. UAE Microbial CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 47. Lonza Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 48. AGC Biologics Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 49. FUJIFILM Diosynth Biotechnologies Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 50. Laurus Bio Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 51. BOC Sciences Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 52. AbbVie Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 53. Cytovance Biologics Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 54. ADL Biopharma Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 55. EUROAPI Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 56. KBI Biopharma Revenue Growth Rate in Microbial CDMO Service Business (2019-2024)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
